D-0297-2022 Class II Terminated

Recalled by Teligent Pharma, Inc. — Buena, NJ

FDA drug recall D-0297-2022 was initiated by Teligent Pharma, Inc. on Aug 23, 2021 and is designated Class II. Reason for recall: Failed Stability Specifications: lot did not meet specification for the Active Pharmaceutical Ingredient (API) particle test, which was determined through routine stability testing The recall status is terminated (terminated Aug 16, 2024). Affected quantity: 3,792 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 5, 2022
Initiation Date
Aug 23, 2021
Termination Date
Aug 16, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,792 bottles

Product description

Betamethasone Dipropionate Lotion USP, 0.05% (Augmented), 30 mL bottle, (29 g), Rx Only, Teligent Pharma Inc., Buena, NJ, 08310, NDC 52565-023-29

Reason for recall

Failed Stability Specifications: lot did not meet specification for the Active Pharmaceutical Ingredient (API) particle test, which was determined through routine stability testing

Distribution pattern

Distributed Nationwide in the USA

Code information

Lot # 16569, Exp 9/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0297-2022
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0297-2022. Report a data issue: hello@regdatalab.com.